Antibody treatment Trump touts relied on testing with cells derived from fetal tissue

NCER Comments:

Both ongoing studies and limited clinical use show promising results for REGN-CoV2 therapy. No aborted fetal tissue was used in the creation of Regeneronʼs COVID-19 and no fetal tissue is contained in the therapy. Two sources of antibodies were used: human and mice. The company has filed for “expanded access” from the FDA, and an Executive Order will allow use of the therapeutic without cost to the patient. However, aborted fetal cells were …